EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Current status of selective nonsteroidal anti-inflammatory drug-COX-2 inhibitor use in outpatients with low back pain and cardiovascular comorbidities: An Analysis of the NAMCS Database

Yujian Liu, Jian Lu, Guangwu Liu

Journal of the Pakistan Medical Association · 2025

DOI: 10.47391/jpma.20611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2025. Verfasst von Yujian Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Hauptthemen laut MEDLINE: Cyclooxygenase 2 Inhibitors, Cardiovascular Diseases, Low Back Pain, Practice Patterns, Physicians'. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyse prescribing patterns of cyclooxygenase-2 inhibitor for low-back pain patients with cardiovascular comorbidities in American outpatient settings.

Method

The data of this retrospective, cross-sectional study were from the 2007-2019 National Ambulatory Medical Care Survey except 2017 for which data were not available. Data related to low-back pain patients of either gender aged >20 years. Those having cardiovascular comorbidities were placed in group A, while those without such comorbidities were placed in group B. Descriptive statistics were employed to evaluate visit characteristics, stratified by cyclooxygenase-2 inhibitor use. Multivariable logistic regression analysis was utilised to assess factors associated with cyclooxygenase-2 inhibitor prescriptions. Data was analysed using R 4.1.2.

Results

Of the 242.65 million patients with 107.19(44.2%) females, 76.83 million (31.7%) were in group A and 165.82 million (68.3%) in group B. Compared to group B patients, those in group A were older (62.0±14.1years vs 49.7±16.1 years, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclooxygenase 2 InhibitorsCardiovascular DiseasesLow Back PainPractice Patterns, Physicians'Anti-Inflammatory Agents, Non-SteroidalHumansFemaleMaleMiddle AgedCross-Sectional StudiesRetrospective StudiesAdultAgedComorbidityOutpatientsUnited States

Stichwörter der Autor:innen

Low-back pain, Comorbidities, Cardiovascular disease.

Substanzen

Cyclooxygenase 2 InhibitorsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
  • School of Mathematics and Computer Science, Wuhan Polytechnic University.
  • Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Liu, Y., Lu, J., & Liu, G. (2025). Current status of selective nonsteroidal anti-inflammatory drug-COX-2 inhibitor use in outpatients with low back pain and cardiovascular comorbidities: An Analysis of the NAMCS Database. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.20611

Vancouver

Liu Y, Lu J, Liu G. Current status of selective nonsteroidal anti-inflammatory drug-COX-2 inhibitor use in outpatients with low back pain and cardiovascular comorbidities: An Analysis of the NAMCS Database. Journal of the Pakistan Medical Association. 2025. doi:10.47391/jpma.20611

BibTeX
@article{Liu2025,
  author = {Liu, Yujian and Lu, Jian and Liu, Guangwu},
  title = {Current status of selective nonsteroidal anti-inflammatory drug-COX-2 inhibitor use in outpatients with low back pain and cardiovascular comorbidities: An Analysis of the NAMCS Database},
  journal = {Journal of the Pakistan Medical Association},
  year = {2025},
  doi = {10.47391/jpma.20611}
}
Kostenlos starten →